[PDF][PDF] Participation of nitric oxide in different models of experimental hypertension.

J Török - Physiological research, 2008 - biomed.cas.cz
Participation of Nitric Oxide in Different Models of Experimental Hypertension Page 1
PHYSIOLOGICAL RESEARCH • ISSN 0862-8408(print) • ISSN 1802-9973(online) © 2008 …

[PDF][PDF] Blood pressure regulation in stress: focus on nitric oxide-dependent mechanisms

A Puzserova, I Bernatova - Physiol Res, 2016 - paulwulleman.be
Blood Pressure Regulation in Stress: Focus on Nitric Oxide-Dependent Mechanisms Page 1
PHYSIOLOGICAL RESEARCH ISSN 0862-8408(print) ISSN 1802-9973(online) © 2016 Institute …

[PDF][PDF] Altered neural and vascular mechanisms in hypertension

M Pintérová, J Kuneš, J Zicha - Physiol Res, 2011 - biomed.cas.cz
Essential hypertension is a multifactorial disorder which belongs to the main risk factors
responsible for renal and cardiovascular complications. This review is focused on the …

Physiological functions of NO-sensitive guanylyl cyclase isoforms

D Koesling, E Mergia… - Current medicinal …, 2016 - ingentaconnect.com
NO-sensitive guanylyl cyclase (NO-GC) acts as the receptor for nitric oxide and by the
increase in cGMP executes most of the NO effects in the cardiovascular and neuronal …

Cardiovascular risk in chronic kidney disease: role of the sympathetic nervous system

J Park - Cardiology research and practice, 2012 - Wiley Online Library
Patients with chronic kidney disease are at significantly increased risk for cardiovascular
disease and sudden cardiac death. One mechanism underlying increased cardiovascular …

Inhibition of nitric oxide synthase evokes central sympatho‐excitation in healthy humans

CN Young, JP Fisher, KM Gallagher… - The Journal of …, 2009 - Wiley Online Library
Animal studies have indicated that nitric oxide is a key signalling molecule involved in the
tonic restraint of central sympathetic outflow from the brainstem. Extension of these findings …

Antihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in L-NAME hypertensive rats

J Zicha, Z Dobešová, J Kuneš - Hypertension research, 2006 - nature.com
Hypertension due to chronic inhibition of NO synthase (NOS) by N ω-nitro-L-arginine methyl
ester (L-NAME) administration is characterized by both impaired NO-dependent vasodilation …

Point of NO return for nitrergic nerves in diabetes: a new insight into diabetic complications

S Cellek - Current pharmaceutical design, 2004 - ingentaconnect.com
Aberrations in nitrergic neurotransmission, due to a decrease in neuronal nitric oxide (NO)
synthase (nNOS) protein, play an important role in the pathogenesis of autonomic …

Pattern of sympathetic vasomotor activity in a model of hypertension induced by nitric oxide synthase blockade

LI Zambrano, RB Pontes, ML Garcia… - Physiological …, 2019 - Wiley Online Library
We aimed to investigate the effects of nitric oxide (NO) synthesis inhibition by NO synthase
inhibitor N‐nitro‐L‐arginine‐methyl ester (L‐NAME) treatment on the sympathetic vasomotor …

The endocrine system in chronic nitric oxide deficiency

F Vargas, JM Moreno, R Wangensteen… - European journal of …, 2007 - academic.oup.com
The experimental model of chronic inhibition of nitric oxide (NO) production has proven to be
a useful tool to study cardiovascular and renal lesions produced by this type of hypertension …